Tectonic Therapeutic (TECX) Cash from Investing Activities Growth (3y) (2020 - 2026)
Tectonic Therapeutic (TECX) Cash from Investing Activities Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Tectonic Therapeutic |
528.16 Mn |
291.27 Mn |
- |
-33.42% |
| Date | Value |
|---|
| Mar 31, 2026 |
-33.42% |
| Sep 30, 2025 |
-24.51% |
| Jun 30, 2025 |
33.31% |
| Mar 31, 2025 |
5.51% |
| Dec 31, 2024 |
84.77% |
| Sep 30, 2024 |
16.94% |
| Jun 30, 2024 |
26.06% |
| Mar 31, 2024 |
67.36% |
| Dec 31, 2023 |
14.85% |
| Sep 30, 2023 |
39.11% |
| Jun 30, 2023 |
24.03% |
| Mar 31, 2023 |
75.98% |
| Sep 30, 2022 |
-3.31% |
| Jun 30, 2022 |
28.11% |
| Mar 31, 2022 |
54.51% |
| Dec 31, 2021 |
-53.72% |
| Sep 30, 2021 |
39.37% |
| Jun 30, 2021 |
-107.78% |
| Mar 31, 2021 |
24.10% |
| Dec 31, 2020 |
0.00% |
